Nkarta (NKTX) News Today $1.82 +0.12 (+6.73%) As of 11:18 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Nkarta's (NKTX) Buy Rating Reiterated at Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and set a $11.00 price objective on shares of Nkarta in a research report on Wednesday.April 11, 2025 | marketbeat.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Phathom Pharmaceuticals (PHAT), Nkarta (NKTX) and Regeneron (REGN)April 9, 2025 | markets.businessinsider.comNkarta to Participate in an April Investor ConferenceApril 1, 2025 | globenewswire.comNkarta: Betting On The TurnaroundMarch 31, 2025 | seekingalpha.comNkarta: Betting On The TurnaroundMarch 31, 2025 | seekingalpha.comNkarta: Grinding Lower, Trying To Find SupportMarch 31, 2025 | seekingalpha.comWhat is HC Wainwright's Forecast for Nkarta Q1 Earnings?Nkarta, Inc. (NASDAQ:NKTX - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of Nkarta in a research note issued to investors on Thursday, March 27th. HC Wainwright analyst E. Bodnar anticipates that the company will posMarch 31, 2025 | marketbeat.comLeerink Partnrs Has Strong Forecast for Nkarta Q1 EarningsNkarta, Inc. (NASDAQ:NKTX - Free Report) - Equities research analysts at Leerink Partnrs upped their Q1 2025 earnings estimates for shares of Nkarta in a report issued on Wednesday, March 26th. Leerink Partnrs analyst D. Graybosch now forecasts that the company will post earnings of ($0.46) per sMarch 31, 2025 | marketbeat.comWilliam Blair Estimates Nkarta's Q1 Earnings (NASDAQ:NKTX)Nkarta, Inc. (NASDAQ:NKTX - Free Report) - William Blair decreased their Q1 2025 earnings per share (EPS) estimates for Nkarta in a research note issued to investors on Thursday, March 27th. William Blair analyst S. Corwin now anticipates that the company will post earnings per share of ($0.44) fMarch 31, 2025 | marketbeat.comHC Wainwright Comments on Nkarta's Q4 Earnings (NASDAQ:NKTX)Nkarta, Inc. (NASDAQ:NKTX - Free Report) - Stock analysts at HC Wainwright issued their Q4 2025 earnings per share estimates for shares of Nkarta in a research report issued on Thursday, March 27th. HC Wainwright analyst E. Bodnar forecasts that the company will earn ($0.29) per share for the quaMarch 29, 2025 | marketbeat.comNkarta (NASDAQ:NKTX) Releases Earnings Results, Beats Expectations By $0.06 EPSNkarta (NASDAQ:NKTX - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.35) EPS for the quarter, topping analysts' consensus estimates of ($0.41) by $0.06.March 28, 2025 | marketbeat.comNkarta, Inc. (NASDAQ:NKTX) Given Average Recommendation of "Buy" by BrokeragesShares of Nkarta, Inc. (NASDAQ:NKTX - Get Free Report) have been given a consensus rating of "Buy" by the eight analysts that are presently covering the firm, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation onMarch 28, 2025 | marketbeat.comNeedham & Company LLC Reaffirms Buy Rating for Nkarta (NASDAQ:NKTX)Needham & Company LLC reissued a "buy" rating and set a $11.00 target price on shares of Nkarta in a research report on Thursday.March 28, 2025 | marketbeat.comNkarta (NASDAQ:NKTX) Price Target Lowered to $14.00 at Stifel NicolausStifel Nicolaus decreased their price objective on shares of Nkarta from $15.00 to $14.00 and set a "buy" rating for the company in a report on Thursday.March 28, 2025 | marketbeat.comNkarta (NASDAQ:NKTX) Receives "Buy" Rating from HC WainwrightHC Wainwright restated a "buy" rating and issued a $18.00 price target on shares of Nkarta in a report on Thursday.March 28, 2025 | marketbeat.comNkarta price target lowered to $14 from $15 at StifelMarch 27, 2025 | markets.businessinsider.comWhy Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday?March 27, 2025 | benzinga.comNkarta announces restructuring and workforce reduction of 34%March 27, 2025 | markets.businessinsider.comTD Cowen Keeps Their Buy Rating on Nkarta (NKTX)March 27, 2025 | markets.businessinsider.comNkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate HighlightsMarch 26, 2025 | globenewswire.comNkarta (NKTX) Projected to Post Earnings on ThursdayNkarta (NASDAQ:NKTX) will be releasing earnings before the market opens on Thursday, March 20, Financial Modeling Prep reports.March 13, 2025 | marketbeat.comNkarta to Participate in March Investor ConferencesFebruary 25, 2025 | globenewswire.comLeerink Partnrs Comments on Nkarta FY2024 EarningsNkarta, Inc. (NASDAQ:NKTX - Free Report) - Analysts at Leerink Partnrs issued their FY2024 earnings per share estimates for Nkarta in a report released on Thursday, February 13th. Leerink Partnrs analyst D. Graybosch expects that the company will post earnings per share of ($1.77) for the year. TFebruary 17, 2025 | marketbeat.comAnalysts Set Expectations for Nkarta FY2029 EarningsNkarta, Inc. (NASDAQ:NKTX - Free Report) - Investment analysts at Leerink Partnrs issued their FY2029 EPS estimates for Nkarta in a research note issued to investors on Thursday, February 13th. Leerink Partnrs analyst D. Graybosch expects that the company will post earnings of ($1.74) per share fFebruary 15, 2025 | marketbeat.comNkarta (NKTX) Gets a Buy from Leerink PartnersFebruary 14, 2025 | markets.businessinsider.comNkarta, Inc. (NASDAQ:NKTX) Given Consensus Rating of "Buy" by BrokeragesNkarta, Inc. (NASDAQ:NKTX - Get Free Report) has been assigned a consensus rating of "Buy" from the seven research firms that are currently covering the stock, Marketbeat reports. Five analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The avFebruary 11, 2025 | marketbeat.comNkarta, Inc. (NASDAQ:NKTX) Insider David Shook Sells 8,638 SharesJanuary 18, 2025 | insidertrades.comJPMorgan Chase & Co. Purchases 761,349 Shares of Nkarta, Inc. (NASDAQ:NKTX)JPMorgan Chase & Co. raised its position in Nkarta, Inc. (NASDAQ:NKTX - Free Report) by 252.1% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,063,362 shares of the company's stock after purchasing an additional 761,349 shares durinJanuary 18, 2025 | marketbeat.comNkarta CEO Paul Hastings sells $38,231 in stockJanuary 18, 2025 | msn.comNkarta, Inc. (NASDAQ:NKTX) Insider Sells $19,003.60 in StockNkarta, Inc. (NASDAQ:NKTX - Get Free Report) insider David Shook sold 8,638 shares of Nkarta stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $2.20, for a total transaction of $19,003.60. Following the sale, the insider now directly owns 190,955 shares in the company, valued at $420,101. The trade was a 4.33 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.January 17, 2025 | marketbeat.comNkarta, Inc. (NASDAQ:NKTX) CEO Sells $38,231.60 in StockNkarta, Inc. (NASDAQ:NKTX - Get Free Report) CEO Paul J. Hastings sold 17,378 shares of the company's stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $2.20, for a total value of $38,231.60. Following the completion of the transaction, the chief executive officer now directly owns 319,859 shares of the company's stock, valued at approximately $703,689.80. The trade was a 5.15 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.January 17, 2025 | marketbeat.comNkarta, Inc. (NASDAQ:NKTX) Given Average Rating of "Buy" by BrokeragesNkarta, Inc. (NASDAQ:NKTX - Get Free Report) has received a consensus recommendation of "Buy" from the seven analysts that are presently covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the compJanuary 17, 2025 | marketbeat.comUnusually active option classes on open January 7thJanuary 7, 2025 | markets.businessinsider.comNkarta, Inc.: Trying To Find Space In A Crowded PlaceJanuary 2, 2025 | seekingalpha.comNkarta, Inc. (NASDAQ:NKTX) Receives Consensus Rating of "Buy" from AnalystsShares of Nkarta, Inc. (NASDAQ:NKTX - Get Free Report) have been assigned an average recommendation of "Buy" from the seven ratings firms that are covering the company, Marketbeat reports. Five equities research analysts have rated the stock with a buy recommendation and two have issued a strong bDecember 23, 2024 | marketbeat.comNkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2December 5, 2024 | globenewswire.comWasatch Advisors LP Raises Position in Nkarta, Inc. (NASDAQ:NKTX)Wasatch Advisors LP raised its stake in shares of Nkarta, Inc. (NASDAQ:NKTX - Free Report) by 31.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,834,680 shares of the company's stock after pDecember 1, 2024 | marketbeat.comNkarta, Inc. (NASDAQ:NKTX) Sees Large Drop in Short InterestNkarta, Inc. (NASDAQ:NKTX - Get Free Report) was the recipient of a significant decrease in short interest in November. As of November 15th, there was short interest totalling 6,770,000 shares, a decrease of 29.3% from the October 31st total of 9,570,000 shares. Based on an average trading volume of 789,300 shares, the days-to-cover ratio is presently 8.6 days.November 29, 2024 | marketbeat.comNkarta, Inc. (NASDAQ:NKTX) Given Consensus Rating of "Buy" by AnalystsShares of Nkarta, Inc. (NASDAQ:NKTX - Get Free Report) have earned a consensus rating of "Buy" from the seven brokerages that are presently covering the company, MarketBeat Ratings reports. Five analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the compaNovember 28, 2024 | marketbeat.comNkarta to Participate in an Upcoming Investor ConferenceNovember 26, 2024 | globenewswire.comNkarta price target lowered to $16 from $20 at MizuhoNovember 22, 2024 | markets.businessinsider.comMizuho Issues Pessimistic Forecast for Nkarta (NASDAQ:NKTX) Stock PriceMizuho cut their price objective on shares of Nkarta from $20.00 to $16.00 and set an "outperform" rating for the company in a research report on Thursday.November 21, 2024 | marketbeat.comNkarta to Participate in an Upcoming Investor ConferenceNovember 12, 2024 | globenewswire.comNkarta (NASDAQ:NKTX) Price Target Cut to $18.00 by Analysts at HC WainwrightHC Wainwright cut their price target on Nkarta from $22.00 to $18.00 and set a "buy" rating for the company in a report on Monday.November 11, 2024 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Nkarta (NKTX) and Veeva Systems (VEEV)November 9, 2024 | markets.businessinsider.comNkarta’s Strategic Shift and Financial Strength Bolster Buy RatingNovember 8, 2024 | markets.businessinsider.comNeedham & Company LLC Issues Pessimistic Forecast for Nkarta (NASDAQ:NKTX) Stock PriceNeedham & Company LLC reduced their target price on Nkarta from $13.00 to $11.00 and set a "buy" rating for the company in a research report on Friday.November 8, 2024 | marketbeat.comTD Cowen Sticks to Its Buy Rating for Nkarta (NKTX)November 8, 2024 | markets.businessinsider.comNkarta Reports Third Quarter 2024 Financial Results and Corporate HighlightsNovember 7, 2024 | globenewswire.comNkarta (NKTX) Stock: Looking For UpsideOctober 31, 2024 | seekingalpha.com Remove Ads Get Nkarta News Delivered to You Automatically Sign up to receive the latest news and ratings for NKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address NKTX Media Mentions By Week NKTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NKTX News Sentiment▼0.710.79▲Average Medical News Sentiment NKTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NKTX Articles This Week▼42▲NKTX Articles Average Week Remove Ads Get Nkarta News Delivered to You Automatically Sign up to receive the latest news and ratings for NKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GH Research News Today Kura Oncology News Today CorMedix News Today Sage Therapeutics News Today Cullinan Therapeutics News Today Maravai LifeSciences News Today Tyra Biosciences News Today SIGA Technologies News Today Relay Therapeutics News Today Akebia Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NKTX) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMusk's panic move: What the world's richest man fears is comingWhether you have modest savings of $10,000 or substantial wealth of $10 million, this information could determ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nkarta, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nkarta With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NKTX Stock Free NKTX Stock Alerts